Hemangioblastoma (central nervous system)
Citation, DOI & article data
Hemangioblastomas are tumors of vascular origin and occur both sporadically and in patients with von Hippel Lindau disease. They are WHO grade 1 tumors, which can occur in the central nervous system or elsewhere in the body, including kidneys, liver, and pancreas.
These tumors generally present on imaging as sharply demarcated homogeneous masses composed of a cyst with non-enhancing walls, a mural nodule which vividly enhances, often with prominent serpentine flow voids.
Hemangioblastomas typically occur in young to middle-aged adults and, although they are the most common primary intra-axial infratentorial tumor in this demographic, they are nonetheless uncommon in absolute terms. They are estimated to account for only 1-2.5% of all intracranial tumors 3,4 and approximately 10% of all posterior fossa tumors 4:
- slight male predilection in adults: M: F ratio of 1.3-2.6:1 4
- peak incidence at around 30-60 years of age, but earlier in patients with vHL
- sporadic cases make up approximately 75-80%, with the remainder being found in patients with vHL
Most frequently present with symptoms relating to:
- headaches: 70% 4
- hydrocephalus and symptoms of raised intracranial pressure: 50% 4
- cerebellar dysfunction: ~50-60% 3
- altered mental state: 10%
- polycythemia due to erythropoietin production occurs in ~20% (range 5-40%) of cases 3,4
One study showed that in vHL patients, the onset of symptoms usually coincides with the development of a cystic component, and they showed that solid cerebellar nodules were mostly well-tolerated. They suggested repeat imaging at this stage to document the size of the cyst and to plan tumor excision 7.
Acute presentation due to significant hemorrhage is uncommon and tends to be seen in larger tumors (>1.5 cm) 5,6.
Hemangioblastoma is actually a capillary hemangioma and, despite the name with the suffix of "blastoma", it is a low grade (WHO grade 1) lesion. The tumor is usually well-circumscribed with a highly vascular mural nodule almost always abutting the pial layer and a peripheral cyst that has similar contents as blood plasma. Hence it is suggested that the cystic component most likely arises by exudation from the solid nodule vascular component 4,9.
It has therefore also been suggested that resection of the cystic component need not be carried out. This has not been supported in a number of other studies however 8,9 (a similar discussion is present in the pilocytic astrocytoma literature).
Cysts that are within the solid nodule, or have peripheral enhancement, are presumably part of the tumor and should, therefore, be resected. The fluid within the cyst is often xanthochromic due to frequent bleeding into the cyst 4.
Microscopy reveals a very vascular tumor composed of two components: neoplastic stromal cells and reactive vascular cells 10. The proportion of these two components is variable. A typical and characteristic finding is of thin-walled vessels with surrounding stroma of connective tissue and polygonal lipid-laden 'stromal cells' 4.
- intracranial: 87-97% 4
- 95% in the posterior fossa
- 85% in cerebellar hemisphere
- 10% in the cerebellar vermis
- 5% medulla
- only rarely do they extend beyond the cerebellum into the cerebellopontine angle 2
- 5% supratentorial (typically in the optic radiations)
- cerebral hemangioblastomas are only really seen in patients with vHL
- 95% in the posterior fossa
- spinal: 3-13% 4
- multiple RCCs
von Hippel Lindau (vHL) disease
- ~45% of those with vHL develop hemangioblastomas
- ~20% of those with hemangioblastoma have vHL
- polycythemia: due to secretion of erythropoietin from lesions
Typically hemangioblastomas (60% of cases) are sharply demarcated homogeneous masses composed of a cyst with non-enhancing walls, except for a mural nodule which vividly enhances and often has prominent serpentine flow voids 2. Not infrequently the mural nodule itself has cystic spaces within it. The solid nodules are commonly seen abutting the pia mater.
In the remaining 40%, the tumor is solid with no cystic cavity 4.
- the mural nodule is isodense to the brain on non-contrast scans with fluid density surrounding cyst
- postcontrast intense homogeneous enhancement of the mural nodule
- the cyst walls do not usually enhance
- calcification is not a feature
- hypointense to isointense mural nodule
- CSF signal cyst content
T1 C+ (Gd)
- mural nodule vividly enhances 2,4
- cyst wall does not enhance 4
- hyperintense mural nodule
- flow voids due to enlarged vessels may be evident especially at the periphery of the cyst, seen in 60-70% of cases 4
- fluid-filled cyst, similar to CSF
- MR perfusion imaging: high rCBV ratios
Enlarged feeding arteries and often dilated draining veins are demonstrated, with a dense tumor blush centrally 4.
Treatment and prognosis
Surgical resection is usually curative, and with large lesions may be made easier by preoperative embolization. Simple cyst drainage appears to be insufficient for definitive management. Adjuvant radiotherapy may be used in patients with incomplete resections. Recurrence can be seen in up to 25% of patients 3.
General imaging differential considerations include:
- brain metastases: although single posterior fossa metastases are uncommon they are still the most common diagnosis if the patient is middle-aged or older
- vascular lesions
- common in childhood
- much more solid
- restricted diffusion (small round blue cell tumor)
- 1. Robert I. Grossman, David M. Yousem. Neuroradiology. (2003) ISBN: 9780323005081 - Google Books
- 2. Bonneville F, Sarrazin J, Marsot-Dupuch K et al. Unusual Lesions of the Cerebellopontine Angle: A Segmental Approach. Radiographics. 2001;21(2):419-38. doi:10.1148/radiographics.21.2.g01mr13419 - Pubmed
- 3. Farrukh H. Cerebellar Hemangioblastoma Presenting as Secondary Erythrocytosis and Aspiration Pneumonia. West J Med. 1996;164(2):169-71. PMC1303396 - Pubmed
- 4. Ho V, Smirniotopoulos J, Murphy F, Rushing E. Radiologic-Pathologic Correlation: Hemangioblastoma. AJNR Am J Neuroradiol. 1992;13(5):1343-52. PMC8335244 - Pubmed
- 5. Gläsker S & Van Velthoven V. Risk of Hemorrhage in Hemangioblastomas of the Central Nervous System. Neurosurgery. 2005;57(1):71-6; discussion 71-6. doi:10.1227/01.neu.0000163250.71951.18 - Pubmed
- 6. de San Pedro J, Rodríguez F, Níguez B et al. Massive Hemorrhage in Hemangioblastomas Literature Review. Neurosurg Rev. 2010;33(1):11-26. doi:10.1007/s10143-009-0217-1 - Pubmed
- 7. Slater A, Moore N, Huson S. The Natural History of Cerebellar Hemangioblastomas in Von Hippel-Lindau Disease. AJNR Am J Neuroradiol. 2003;24(8):1570-4. PMC7973972 - Pubmed
- 8. Utsuki S, Oka H, Kijima C, Miyajima Y, Hagiwara H, Fujii K. Utility of Intraoperative Fluorescent Diagnosis of Residual Hemangioblastoma Using 5-Aminolevulinic Acid. Neurol India. 2011;59(4):612-5. doi:10.4103/0028-3886.84349 - Pubmed
- 9. Raz E, Zagzag D, Saba L et al. Cyst with a Mural Nodule Tumor of the Brain. Cancer Imaging. 2012;12(1):237-44. doi:10.1102/1470-7330.2012.0028 - Pubmed
- 10. Tihan T, Fanburg-Smith J, Vortmeyer AO, Zagzag D, Haemangioblastoma. In: WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 6). https://publications.iarc.fr/601